Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.39B P/E - EPS this Y -9.90% Ern Qtrly Grth -
Income -96.75M Forward P/E -13.64 EPS next Y -54.00% 50D Avg Chg -25.00%
Sales - PEG -1.62 EPS past 5Y - 200D Avg Chg 10.00%
Dividend N/A Price/Book 3.60 EPS next 5Y 40.00% 52W High Chg -46.00%
Recommedations 1.40 Quick Ratio 37.55 Shares Outstanding 110.80M 52W Low Chg 449.00%
Insider Own 5.98% ROA -11.57% Shares Float 104.86M Beta 1.02
Inst Own 75.17% ROE -14.80% Shares Shorted/Prior 15.10M/12.67M Price 13.91
Gross Margin - Profit Margin - Avg. Volume 2,851,827 Target Price 113.36
Oper. Margin - Earnings Date Oct 23 Volume 1,253,300 Change -1.77%
About Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Viking Therapeutics, Inc. News
07/26/24 June PCE inflation print, auto earnings: Morning Brief
07/26/24 Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
07/26/24 Eli Lilly loses $120B in value over Viking's GLP-1 progress
07/25/24 Why Weight Loss Drug Developer Stocks Tumbled on Thursday
07/25/24 Viking Therapeutics Unveils Monthly Weight-Loss Shot, Rocking Eli Lilly, Novo Nordisk
07/25/24 Why Viking’s Weight-Loss Drug News Is Weighing on Eli Lilly, Novo Nordisk Stocks
07/25/24 Why Viking Therapeutics Stock Is Skyrocketing Today
07/25/24 Viking Therapeutics weight-loss drug moves to Phase 3 trial
07/25/24 Viking (VKTX) Q2 Earnings Beat, Stock Up on Pipeline Updates
07/25/24 Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill
07/25/24 Viking shares jump on plans to speed obesity drug into late-stage testing
07/25/24 Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
07/24/24 Viking Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
07/24/24 The Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards Lifesciences
07/23/24 Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
07/22/24 Missed Out on Eli Lilly? These 2 Healthcare Stocks Have Big Catalysts on the Horizon.
07/21/24 This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes
07/20/24 3 Monster Stocks in the Making to Buy Right Now
07/19/24 Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know
07/19/24 Should Viking (VKTX) Stock be in Your Portfolio Pre-Q2 Earnings?
VKTX Chatroom

User Image srinik23 Posted - 2 hours ago

$VKTX @KungFuNinja @deerhtide @DG20 Some questions/thoughts (tagging some that discussed this before). 1. Agree for 3p to get involved in p3 trial design - have to move quick - but BL also said the early parts of p3 is standard so might not need immediately. I hope 3p moves quickly. 2. BL, Chairman, and 2 others started NEW 105b-1s implemented in May of this year (look in recently filed 10Q). This SCARES me - b/c can't initiate new one when in possession of MNPI. So does that mean there were no "live" discussions on BO in May. That's possible - but that would suggest slower timeline if nothing live until June at earliest. Also wild BL looking to sell 330,000 shares via 105b-1 now. Thoughts? 3. Hope they release 60 80 100 soon - before OW. Need the momentum to keep going. To get quant funds to stay involved/get involved. GL GL

User Image BearBullyJack Posted - 2 hours ago

@CallThemOut your statement is kind of contradictory because Melissa might have made that statement but for months Cramer has been ripping on $VKTX. He despises any progress it’s been making and shoots down any claims they have chance so your assumption this has any positive affect on Viking is not adding up

User Image BearBullyJack Posted - 2 hours ago

$VKTX ALT has $182 million in cash, end of Phase 2 meeting and earning call coming up soon. MASH drug has fast track approval…how exactly are they going to bring a weight loss drug through Phase 3 without a cash raise? At $6 bucks a pop, that’s a huge dilution. Even if MASH drug goes through to making revenue…what…they’re just going to pause their Phase 3 obesity trial? They literally don’t have the option to GIA, they have to be bought out to bring Pemvi through Phase 3

User Image BloodyPortfolio Posted - 3 hours ago

GIA with partnership has longer timeline but the final reward can be enormous compared to cash. Stock or CVR transaction also can be better than cash. One thing for sure is I am not gonna lose sleep over $vktx

User Image FATSTAX Posted - 3 hours ago

$VKTX Monthly: Heavy pro (institutions) activity = white candles with gray background 10 ema = silver line Noted price action marked with timestamped line Continued build over last month's $65.42 heavy pro action high confirms the pro 10 ema defense & is an all-time high breakout threat Live Annotated Charts, trade ideas, & trades, in the best free trading chat

User Image TrustButVerifi Posted - 3 hours ago

$VKTX 100%, All the cards have been flipped over , now Cash Talks! Bullshit Walks! BO imminent!

User Image BloodyPortfolio Posted - 3 hours ago

$VKTX Most contenders have fairly good efficacy but tolerability is what governs final commercial success. Drive for Show, Putt for Dough! For those interested parties, what more data you want? BL already gave you everything. The only missing piece is oral 100mg. If no BO by Sept. or Oct. we will likely need to wait for another 2 years. Hurry if you want to sit at the table with FDA for EOP2/P3. BL has 300yd drive and single putt out. It's time for you to concede! $MRK $PFE $REGN

User Image Galactic_Stock_Savant Posted - 3 hours ago

$VKTX this is a 150-205$ stock man , chart is beautiful

User Image TrustButVerifi Posted - 4 hours ago

$VKTX and any a$$wipe long here who thinks they know more than the rest and CEO and constantly insult other longs should also STFU and be respectful of other longs here.

User Image Faithfull3 Posted - 4 hours ago

$INM $VKTX it's a joke to see a price so low for months. Inmed Pharmaceutiques will sell medical and food products. What could be better and more natural for weight loss than rare CBD. I don't yet understand why the CEO hasn't talked about it yet. A big communications problem. Next week? Last year, 16$....it's a joke. SERIOUSLY.

User Image TrustButVerifi Posted - 4 hours ago

$VKTX All the Nubies who show up on this thread and offer your opinions (u know what they about opinions) should do yourself a favor and do some due diligence on this ticker and buy some share , STFU, and send the longs here a big Thank You after you triple your money.

User Image TrustButVerifi Posted - 4 hours ago

$LLY $VKTX Lilly is the most over inflated pharma out there Rude awakening coming to share holders!

User Image rahod Posted - 4 hours ago

$VKTX $LLY It’s a year or two away and LLY isn’t sitting still. This sell off is WAY off the mark providing a huge opportunity for LLY investors

User Image uknic Posted - 4 hours ago

$VKTX happy weekend Vikings

User Image SNOT_BROTHER Posted - 4 hours ago

$VKTX Great week Vikings!!! Know what you OWN and pick your spots to add until next catalyst or potentially the final catalyst. Commons, no margin, hold, period…

User Image Blink182rulez Posted - 4 hours ago

@Rhody27 i think competition from $VKTX in the future is why it got hit

User Image qtheeskimo Posted - 6 hours ago

$VKTX https://seekingalpha.com/article/4706587?gt=ff54f01f8e32591f

User Image KungFuNinja Posted - 7 hours ago

$VKTX Weekend Thoughts For Some Discussion/Fun: I seem to recall that BL (or one of the analysts—maybe someone with knowledge has a source) has mentioned that a potential partner/acquirer will want to be involved in the phase 3 design. With typical acquisitions taking 60-90 days, my question/thought is this: does the deal have to be finalized before the acquiring company can join Viking in FDA meeting this year? If so, things could already be in motion…

User Image GSCCPA Posted - 7 hours ago

I just put some money in $TNXP. Its 0.55/sh. they just signed contract with DOD & $TNXP Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia. I like $ALT too. not very much $$$ in $TNXP. Happy with $VKTX

User Image Aces_n_Eights Posted - 7 hours ago

$VKTX If we can make an impact this big on another company that is over 100 times bigger than us feel like we have some massive potential.

User Image BillyGonebroke Posted - 8 hours ago

$VKTX Pretty wild swings last few days.

User Image crabbypatty31 Posted - 8 hours ago

@Braverabbit Wise words from you! Buying stocks hoping for a BO does involve an incredible amount of risk. I've only had it come through once and right before the BO the stock cratered and I almost sold. So glad I didn't:) Stock symbol was $PRVB - another biotech. I hold some shares of $ALT and $PARA and hope a BO will happen for one or both down the line. I need a winner! Good luck to you and $VKTX:))

User Image deerhtide Posted - 9 hours ago

$VKTX what was once pretty predictable with Viking has now become unpredictable in a good way. Even better days ahead.

User Image Theflash88 Posted - 9 hours ago

$VKTX We all should be happy this week. Surprised of the rude comments on here… unless they are short.. Imo. $VKTX can make us all a lot of $$$.. the more you can invest the more you’ll make . I have 1/4 of my $$$ in Viking.. I feel the risk / reward is in favor of the longs. I may add more as we go along but I need money for other promising stocks. A couple are $RNA and DYN.. let’s hear your favorites. Let’s work together here.

User Image GettnFibbywIT Posted - 9 hours ago

$VKTX A few areas above/below worth noting......

User Image Theflash88 Posted - 9 hours ago

$VKTX No.. not enough.. now it’s $25-30 billion.

User Image Theflash88 Posted - 9 hours ago

$MAXN $VKTX That’s ok.. look at the chart.

User Image Theflash88 Posted - 9 hours ago

$VKTX it’s ok.. UP $1.30.

User Image crabbypatty31 Posted - 9 hours ago

@Braverabbit What makes me wince is the fact that I sold thousands of shares of $VKTX for $6 after holding it for years (in the red.) I know everyone has stories like this but this one makes me weep!! Very excited for all longs and hoping the BO happens soon:)

User Image angelinvesting369 Posted - 10 hours ago

$VKTX $LLY Viking holds so much promise I hope Lilly just buys them now while they are cheap to protect their cash cow. That being said the drop from $900s to $800 in Lilly is a tremendous buying opportunity as they own the Glp-1 market for the next few years. Glp-1 $

Analyst Ratings
Raymond James Strong Buy Jul 25, 24
HC Wainwright & Co. Buy Jul 25, 24
Morgan Stanley Overweight Jun 27, 24
HC Wainwright & Co. Buy Jun 24, 24
Truist Securities Buy Jun 17, 24
Raymond James Strong Buy Jun 4, 24
Maxim Group Buy Jun 4, 24
HC Wainwright & Co. Buy Jun 4, 24
Raymond James Strong Buy May 16, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Lian Brian President & CEO President & CEO Jan 31 Sell 24.7 85,000 2,099,500 2,264,882 01/31/24
Lian Brian President & CEO President & CEO Jan 31 Option 1.23 85,000 104,550 2,349,882 01/31/24
Lian Brian President & CEO President & CEO Jan 30 Sell 23.95 35,000 838,250 2,264,882 01/30/24
Lian Brian President & CEO President & CEO Jan 30 Option 1.23 35,000 43,050 2,299,882 01/30/24
Rouan Sarah Kathryn Director Director Jan 19 Sell 23.05 30,000 691,500 01/19/24
Rouan Sarah Kathryn Director Director Jan 19 Option 8.32 30,000 249,600 30,000 01/19/24
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Jan 03 Sell 17.9 15,000 268,500 180,730 01/04/24
Rowland Charles A Jr Director Director May 16 Option 1.08 40,000 43,200 70,000 05/18/23
Rowland Charles A Jr Director Director May 16 Sell 25 40,000 1,000,000 30,000 05/18/23
MACARTNEY LAWSON Director Director May 16 Sell 24 16,000 384,000 47,965 05/18/23
MACARTNEY LAWSON Director Director May 16 Option 1.19 16,000 19,040 63,965 05/18/23
Lian Brian President & CEO President & CEO May 01 Sell 22.45 45,000 1,010,250 2,197,963 05/01/23
MACARTNEY LAWSON Director Director Apr 24 Sell 22 16,000 352,000 47,965 04/24/23
MACARTNEY LAWSON Director Director Apr 24 Option 3.33 16,000 53,280 63,965 04/24/23
Lian Brian President & CEO President & CEO Apr 19 Sell 21.45 35,000 750,750 2,242,963 04/21/23
MACARTNEY LAWSON Director Director Apr 17 Sell 20 20,786 415,720 47,965 04/18/23
MACARTNEY LAWSON Director Director Apr 17 Option 8 20,786 166,288 68,751 04/18/23
Lian Brian President & CEO President & CEO Apr 17 Sell 20.45 155,000 3,169,750 2,277,963 04/18/23
Lian Brian President & CEO President & CEO Apr 17 Option 2.15 125,000 268,750 2,432,963 04/18/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Apr 17 Sell 20 12,500 250,000 287,763 04/18/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Apr 17 Option 13.07 12,500 163,375 300,263 04/18/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 17 Sell 20 7,500 150,000 149,279 04/18/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 17 Option 13.07 7,500 98,025 156,779 04/18/23
Lian Brian President & CEO President & CEO Apr 13 Sell 18.45 79,336 1,463,749 2,307,963 04/13/23
Lian Brian President & CEO President & CEO Apr 13 Option 1.88 54,336 102,152 2,387,299 04/13/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 11 Sell 18 97,839 1,761,102 149,279 04/13/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Apr 11 Option 6.12 97,839 598,775 190,823 04/13/23
Lian Brian President & CEO President & CEO Mar 30 Sell 17.43 243,352 4,241,625 2,232,963 04/03/23
Lian Brian President & CEO President & CEO Mar 30 Option 6.74 203,352 1,370,592 2,322,933 04/03/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Mar 30 Sell 17.5 161,940 2,833,950 147,778 04/03/23
ZANTE GREG Chief Financial Offi.. Chief Financial Officer Mar 30 Option 6.55 124,661 816,530 178,689 04/03/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 30 Option 9.92 72,200 716,224 261,895 04/03/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 28 Sell 15.5 237,805 3,685,978 261,895 03/30/23
Mancini Marianna Chief Operating Offi.. Chief Operating Officer Mar 28 Option 2.98 182,427 543,632 303,137 03/30/23